Alyeska Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-217,774
Closed -$11.8M 510
2015
Q2
$11.8M Buy
+217,774
New +$12.2M 0.13% 211
2014
Q1
Sell
-235,800
Closed -$11.3M 371
2013
Q4
$11.3M Sell
235,800
-293,440
-55% -$13.4M 0.44% 82
2013
Q3
$24M Buy
529,240
+322,260
+156% +$14.7M 0.98% 22
2013
Q2
$9.17M Buy
+206,980
New +$9.24M 0.45% 72

Other funds holding MRK

Alyeska Investment Group's MRK Position: Q1 2026 in Review

Alyeska Investment Group increased its Merck (MRK) stake by 46% in Q1 2026, buying an estimated $84.1M and bringing the position to 2,305,574 shares worth $277M. The position accounts for 0.78% of the portfolio, ranked #14.

Alyeska Investment Group first reported a position in MRK in Q3 2013 and has held it in 15 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Alyeska Investment Group held 2,305,574 shares of Merck worth $277M as of Q1 2026.
  • Alyeska Investment Group bought 728,862 Merck shares in Q1 2026, an estimated $84.1M.
  • Merck made up 0.78% of Alyeska Investment Group's portfolio in Q1 2026, its #14 holding.
  • Alyeska Investment Group first reported a position in Merck in Q3 2013 and has held it in 15 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.